Transcatheter Aortic Valve Implantation/Replacement

DEVICE2 trials

Sponsors

Boston Scientific Corporation

Conditions

Aortic DiseasesAortic Valve CalcificationAortic Valve Stenosis

Unknown Phase

ACURATE neo2™ Post Market Clinical Follow up Study

Active, not recruitingNCT04655248

Boston Scientific CorporationAortic Diseases, Aortic Valve Calcification, Aortic Valve Stenosis

Start: 2020-12-16End: 2026-12-31Updated: 2025-06-25

ACURATE Enhance Post Market Study

WithdrawnNCT06959862

Boston Scientific CorporationAortic Diseases, Aortic Valve Calcification, Aortic Valve Stenosis

Start: 2025-05-31End: 2027-04-30Updated: 2025-06-24

Related Papers

Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-yearresults of the ACURATE neo2 PMCF Study

EuroIntervention2023-12-2913 citations